Latest News by Industry
EyePoint Pharmaceuticals, Inc. [EYPT] has reported fiscal Q1 loss of $21.20 million.
On a per-share basis, the DE based company said its diluted earnings are $0.56.
The Laboratory Analytical Instruments firm posted revenue of $7.70 million in this period.